Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Truntzer

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2018
Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer PatientsCorentin Richard, Jean-David Fumet, Sandy Chevrier, et al.
Cancer Research|November 6, 2025
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal CancerJean-David Fumet, Charlène Latour, Lisa Nuttin, et al.
Cancers|January 8, 2023
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies <i>CDH17</i> and <i>LRP2</i> as Risk Recurrence Factors in Stage II Colon CancerBenjamin Tournier, Romain Aucagne, Caroline Truntzer, et al.
Cancers|September 10, 2021
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian CancerJulie Lecuelle, Romain Boidot, Hugo Mananet, et al.
Oncoimmunology|January 3, 2024
CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapyCoralie Schoumacher, Valentin Derangère, Gwladys Gaudillière-Le Dain, et al.
BMC Genomics|March 14, 2015
Genetic diversity and trait genomic prediction in a pea diversity panelJudith Burstin, Pauline Salloignon, Marianne Chabert-Martinello, et al.
Oncoimmunology|July 7, 2017
Immune classifications with cytotoxic CD8<sup>+</sup> and Th17 infiltrates are predictors of clinical prognosis in glioblastomaRachid Madkouri, Coureche Guillaume Kaderbhai, Aurélie Bertaut, et al.
Journal of Proteomics|August 2, 2015
Multi-omics profiling reveals that eating difficulties developed consecutively to artificial nutrition in the neonatal period are associated to specific saliva compositionMartine Morzel, Eric Neyraud, Hélène Brignot, et al.
Ebiomedicine|June 16, 2024
Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohortsJulie Lecuelle, Caroline Truntzer, Debora Basile, et al.
Oncotarget|August 4, 2016
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastomaAurélie Bertaut, Caroline Truntzer, Rachid Madkouri, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2018
Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer PatientsCorentin Richard, Jean-David Fumet, Sandy Chevrier, et al.
Cancer Research|November 6, 2025
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal CancerJean-David Fumet, Charlène Latour, Lisa Nuttin, et al.
Cancers|January 8, 2023
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies <i>CDH17</i> and <i>LRP2</i> as Risk Recurrence Factors in Stage II Colon CancerBenjamin Tournier, Romain Aucagne, Caroline Truntzer, et al.
Cancers|September 10, 2021
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian CancerJulie Lecuelle, Romain Boidot, Hugo Mananet, et al.
Oncoimmunology|January 3, 2024
CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapyCoralie Schoumacher, Valentin Derangère, Gwladys Gaudillière-Le Dain, et al.
BMC Genomics|March 14, 2015
Genetic diversity and trait genomic prediction in a pea diversity panelJudith Burstin, Pauline Salloignon, Marianne Chabert-Martinello, et al.
Oncoimmunology|July 7, 2017
Immune classifications with cytotoxic CD8<sup>+</sup> and Th17 infiltrates are predictors of clinical prognosis in glioblastomaRachid Madkouri, Coureche Guillaume Kaderbhai, Aurélie Bertaut, et al.
Journal of Proteomics|August 2, 2015
Multi-omics profiling reveals that eating difficulties developed consecutively to artificial nutrition in the neonatal period are associated to specific saliva compositionMartine Morzel, Eric Neyraud, Hélène Brignot, et al.
Ebiomedicine|June 16, 2024
Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohortsJulie Lecuelle, Caroline Truntzer, Debora Basile, et al.
Oncotarget|August 4, 2016
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastomaAurélie Bertaut, Caroline Truntzer, Rachid Madkouri, et al.
Pageof 11